Home » Stocks » ITMR

Itamar Medical Ltd. (ITMR)

Stock Price: $21.82 USD -0.80 (-3.54%)
Updated May 12, 2021 1:15 PM EDT - Market closed
Market Cap 381.09M
Revenue (ttm) 41.03M
Net Income (ttm) -10.94M
Shares Out 16.39M
EPS (ttm) -0.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 12
Last Price $21.82
Previous Close $22.62
Change ($) -0.80
Change (%) -3.54%
Day's Open 22.08
Day's Range 21.39 - 22.30
Day's Volume 10,881
52-Week Range 12.68 - 29.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 hour ago - Zacks Investment Research

CAESAREA, Israel, May 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management i...

2 days ago - GlobeNewsWire

CAESAREA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management i...

1 week ago - GlobeNewsWire

Significant Majority Expect Home Sleep Apnea Test Usage to Expand and in-lab Usage to Decline

1 month ago - GlobeNewsWire

Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -7.14% and 0.57%, respectively, for the quarter ended December 2020.

2 months ago - Zacks Investment Research

Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share fell 400.00% over the past year to ($0.15), which missed the estima...

2 months ago - Benzinga

- Record Fourth Quarter 2020 Revenues Increase 31% to $ 12.8 Million -

2 months ago - GlobeNewsWire

CAESAREA, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management ...

2 months ago - GlobeNewsWire

CAESAREA, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical dev...

3 months ago - GlobeNewsWire

CAESAREA, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and comme...

3 months ago - GlobeNewsWire

CAESAREA, Israel, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and comme...

3 months ago - GlobeNewsWire

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, February 4th by Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), please note that the contact...

3 months ago - GlobeNewsWire

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and comme...

3 months ago - GlobeNewsWire

CAESAREA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management ...

3 months ago - GlobeNewsWire

This $356 million market cap sleep apnea company is betting it can triple its market cap. If history is any guide, it will return nearly 30% a year.

3 months ago - Forbes

CAESAREA, Israel, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management ...

4 months ago - GlobeNewsWire

CAESAREA, Israel, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management ...

4 months ago - GlobeNewsWire

Positive Coverage Policy from Health Care Service Corporation (HCSC) Covers Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma and Texas Positive Coverage Policy from Health Care ...

4 months ago - GlobeNewsWire

WatchPAT™ to effectively maintain current reimbursement levels despite broader reduction in conversion rates WatchPAT™ to effectively maintain current reimbursement levels despite broader reduction in c...

5 months ago - GlobeNewsWire

Results Further Support Use of WatchPAT for Home-Based Sleep Apnea Testing as an Effective Alternative to In-Lab PSG Testing Results Further Support Use of WatchPAT for Home-Based Sleep Apnea Testing as...

5 months ago - GlobeNewsWire

CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non-i...

5 months ago - GlobeNewsWire

Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Initial findings show potential for material short-term annual savings of up to $5,000 per cardiovascular patient when treated for sleep apnea Initial findings show potential for material short-term ann...

5 months ago - GlobeNewsWire

- Third Quarter Revenues Increase 36 % to $ 11.0 Million -

5 months ago - GlobeNewsWire

CAESAREA, Israel, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical...

6 months ago - GlobeNewsWire

CAESAREA, Israel, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other res...

6 months ago - GlobeNewsWire

Q3 Total Revenue Results of $10.7 M to $ 11 . 0 M , reflecting growth of 32 %- 36 %

6 months ago - GlobeNewsWire

CAESAREA, Israel, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other res...

7 months ago - GlobeNewsWire

Updated guidelines represent a significant milestone in the adoption of Itamar’s Peripheral Arterial Tonometry (PAT) based Home Sleep Apnea Testing (HSAT) in Europe, following adoption in the UK, Hollan...

7 months ago - GlobeNewsWire

CAESAREA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of no...

8 months ago - GlobeNewsWire

CAESAREA, Israel, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non...

8 months ago - GlobeNewsWire

As a platinum sponsor, Itamar Medical’s virtual booth and on-demand content to be offered to SLEEP 2020 attendees As a platinum sponsor, Itamar Medical’s virtual booth and on-demand content to be offere...

8 months ago - GlobeNewsWire

Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of 10.53% and 12.18%, respectively, for the quarter ended June 2020.

9 months ago - Zacks Investment Research

Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

9 months ago - Zacks Investment Research

CAESAREA, Israel, July 27, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medic...

9 months ago - GlobeNewsWire

Itamar Medical (ITMR) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

Itamar Medical Ltd. Sponsored ADR (ITMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

10 months ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor in Itamar Medical.

11 months ago - Zacks Investment Research

- First Quarter 2020 Revenues Increase 38% to $8.4 Million -

11 months ago - GlobeNewsWire

Complete, home-based solution for diagnosing respiratory sleep disorders approved for commercialization in Europe and other CE Mark geographies Complete, home-based solution for diagnosing respiratory s...

1 year ago - GlobeNewsWire

Study conducted at Mount Sinai Hospital in New York City designed to demonstrate benefit of continuous positive airway pressure (CPAP) in delaying or eliminating hospitalization and/or ventilation in pa...

1 year ago - GlobeNewsWire

- Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests -

1 year ago - GlobeNewsWire

Streamlining the complex process from sleep apnea diagnosis to treatment using digital health platforms meets shared mission of addressing the growing and undermanaged sleep apnea epidemic

1 year ago - GlobeNewsWire

CAESAREA, Israel, March 20, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq:  ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive med...

1 year ago - GlobeNewsWire

Study will evaluate how raw signals from tens of thousands of WatchPAT recordings conducted over the last 10 years in combination with health medical records can be leveraged to predict cardiovascular o...

1 year ago - GlobeNewsWire

Two additional published studies highlight WatchPAT’s accuracy and effectiveness in patients with Central Sleep Apnea (CSA) and Chronic Obstructive Pulmonary Disease (COPD)

1 year ago - GlobeNewsWire

CAESAREA, Israel, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medic...

1 year ago - GlobeNewsWire

CAESAREA, Israel, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medic...

1 year ago - GlobeNewsWire

CAESAREA, Israel, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medic...

1 year ago - GlobeNewsWire

About ITMR

Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses e... [Read more...]

Industry
Medical Devices
Founded
1997
Stock Exchange
NASDAQ
Ticker Symbol
ITMR
Full Company Profile

Financial Performance

In 2020, Itamar Medical's revenue was $41.03 million, an increase of 31.28% compared to the previous year's $31.26 million. Losses were -$10.94 million, 107.6% more than in 2019.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for Itamar Medical stock is "Strong Buy." The 12-month stock price forecast is 30.92, which is an increase of 41.70% from the latest price.

Price Target
$30.92
(41.70% upside)
Analyst Consensus: Strong Buy